<SEC-DOCUMENT>0001104659-23-104743.txt : 20230928
<SEC-HEADER>0001104659-23-104743.hdr.sgml : 20230928
<ACCEPTANCE-DATETIME>20230928160741
ACCESSION NUMBER:		0001104659-23-104743
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230925
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230928
DATE AS OF CHANGE:		20230928

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Transcode Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001829635
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				811065054
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40363
		FILM NUMBER:		231289606

	BUSINESS ADDRESS:	
		STREET 1:		6 LIBERTY SQUARE
		STREET 2:		#2382
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
		BUSINESS PHONE:		857-301-6857

	MAIL ADDRESS:	
		STREET 1:		6 LIBERTY SQUARE
		STREET 2:		#2382
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2327131d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:rnaz="http://transcodetherapeutics.com/20230925">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_rnaz_transcodetherapeutics.com_20230925 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20230925_20230925 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0001829635 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:EntityCentralIndexKey">0001829635</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rnaz-20230925.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-09-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001829635</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-25</xbrli:startDate>
        <xbrli:endDate>2023-09-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>



<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20230925__20230925_zRNKTHIwdmXc"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event
reported): <span id="xdx_90D_edei--DocumentPeriodEndDate_c20230925__20230925_znFKAcx2KRFa"><ix:nonNumeric contextRef="AsOf2023-09-25" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">September 25, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_905_edei--EntityRegistrantName_c20230925__20230925_zQ9XfWwhhHk9"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:EntityRegistrantName">TRANSCODE THERAPEUTICS, INC.</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter) </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20230925__20230925_zcLssd0Vxa06"><ix:nonNumeric contextRef="AsOf2023-09-25" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_904_edei--EntityFileNumber_c20230925__20230925_zF7aQE36RvN"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:EntityFileNumber">001-40363</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20230925__20230925_zxcdQsIxgWCh"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:EntityTaxIdentificationNumber">81-1065054</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other jurisdiction</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of incorporation)</b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Commission</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>File Number)</b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(I.R.S. Employer</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Identification No.)</b></p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TransCode
Therapeutics, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20230925__20230925_zOYxjTlDwGgj"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:EntityAddressAddressLine1">6 Liberty Square</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressAddressLine2_c20230925__20230925_zT4LAe1S6HA2"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:EntityAddressAddressLine2">#2382</ix:nonNumeric></span></b> <br />
<b><span id="xdx_903_edei--EntityAddressCityOrTown_c20230925__20230925_zdBwK5zqySIk"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:EntityAddressCityOrTown">Boston</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressStateOrProvince_c20230925__20230925_z3qfyPRSR3Af"><ix:nonNumeric contextRef="AsOf2023-09-25" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span></b> <span style="font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressPostalZipCode_c20230925__20230925_znG7usuZrnce"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:EntityAddressPostalZipCode">02109</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>(Address
of principal executive offices, including zip code)</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_903_edei--CityAreaCode_c20230925__20230925_zZIz9u7J4UL6"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:CityAreaCode">857</ix:nonNumeric></span></b><b>)
<span id="xdx_904_edei--LocalPhoneNumber_c20230925__20230925_zxabP9ifhdgj"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:LocalPhoneNumber">837-3099</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Registrant&#8217;s telephone number, including
area code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former Name or Former Address, if Changed
Since Last Report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form&#160;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_902_edei--WrittenCommunications_c20230925__20230925_zIGUr3OAxal8"><ix:nonNumeric contextRef="AsOf2023-09-25" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font-size: 10pt">Written communications pursuant to Rule&#160;425 under the Securities Act (17&#160;CFR 230.425) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90B_edei--SolicitingMaterial_c20230925__20230925_z8mCQup8nbY5"><ix:nonNumeric contextRef="AsOf2023-09-25" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17&#160;CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20230925__20230925_zP4ZhtPdWuS7"><ix:nonNumeric contextRef="AsOf2023-09-25" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17&#160;CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20230925__20230925_zLE2pGtgWAA1"><ix:nonNumeric contextRef="AsOf2023-09-25" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17&#160;CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered or to be registered pursuant to Section 12(b) of the Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 38%; text-align: center"><b>Title of each class</b></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><b>Trading symbol(s)</b></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 38%; text-align: center"><b>Name of each exchange on which <br />
registered</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--Security12bTitle_c20230925__20230925_zlW95gV6WAvi"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90D_edei--TradingSymbol_c20230925__20230925_zbGq3hr6n937"><ix:nonNumeric contextRef="AsOf2023-09-25" name="dei:TradingSymbol">RNAZ</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>The<span id="xdx_902_edei--SecurityExchangeName_c20230925__20230925_z9AvZvcUrvzh"> <ix:nonNumeric contextRef="AsOf2023-09-25" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Capital Market</b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule&#160;12b-2 of the Securities
Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Emerging growth company&#160;&#160;<span style="font-family: Wingdings"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20230925__20230925_zPIAX9HpPrOb"><ix:nonNumeric contextRef="AsOf2023-09-25" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#120;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90B_edei--EntityExTransitionPeriod_c20230925__20230925_z0YJX6lt0oVa"><ix:nonNumeric contextRef="AsOf2023-09-25" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in; text-align: left"><b>Item 1.01</b></td><td style="text-align: justify"><b>Entry
into a Material Definitive Agreement.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September&#160;25, 2023, <span style="background-color: white">TransCode
Therapeutics,&#160;Inc., a Delaware corporation (the &#8220;Company&#8221;),&#160;</span>entered into an underwriting agreement (the &#8220;Underwriting
Agreement&#8221;) with ThinkEquity LLC, as underwriter (the &#8220;Underwriter&#8221;), pursuant to which the Company agreed to issue
and sell, in a public offering (the &#8220;Offering&#8221;), an aggregate of (i)&#160;700,000 shares (&#8220;Shares&#8221;) of the Company&#8217;s
common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), and (ii)&#160;pre-funded warrants (&#8220;Pre-Funded Warrants&#8221;)
to purchase 16,163,000 shares of Common Stock, including 1,163,000 Pre-Funded Warrants pursuant to the partial exercise of the Underwriter&#8217;s
over-allotment option to purchase up to 2,339,200 additional shares of Common Stock and/or Pre-Funded Warrants. The Shares were sold at
a public offering price of $0.51 per Share, and the Pre-Funded Warrants were sold at a public offering price of $0.50 per Pre-Funded Warrant,
which represents the per share public offering price for the common stock less the $0.01 per share exercise price for each such Pre-Funded
Warrant. The total gross proceeds from the Offering, before deducting underwriting discounts and commissions and other offering expenses
payable by the Company, are approximately $8.5 million. The Company also issued Underwriter&#8217;s Warrants to the Underwriter, exercisable
to purchase 843,150 shares of Common Stock, at an exercise price of $0.6375 per share. The offering closed on September&#160;28, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The representations, warranties and covenants contained in the Underwriting
Agreement were made solely for the benefit of the parties to the Underwriting Agreement. In addition, such representations, warranties
and covenants (i)&#160;are intended as a way of allocating risk between the parties to the Underwriting Agreement and not as statements
of fact, and (ii)&#160;may apply standards of materiality in a way that is different from what may be viewed as material by stockholders
of, or other investors in, the Company. Moreover, information concerning the subject matter of the representations and warranties may
change after the date of the Underwriting Agreement, which subsequent information may or may not be fully reflected in public disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The offering was made pursuant to a registration statement on Form&#160;S-1
(Registration Statement No.&#160;333-274251) filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on August&#160;29,
2023, and <span style="background-color: white">amended on September&#160;11, 2023, and September&#160;25, 2023, and was declared effective
by the Commission on September&#160;25, 2023</span>. A copy of the form of the Underwriting Agreement is filed as Exhibit&#160;1.1 to
this report and the description of the terms of the Underwriting Agreement is qualified in its entirety by reference to such exhibit.
The form of Pre-Funded Warrant is filed as Exhibit&#160;4.1 to this report and the description of the terms of the Pre-Funded Warrants
is qualified in its entirety by reference to such exhibit. The form of Underwriter&#8217;s Warrant is filed as Exhibit&#160;4.2 to this
report and the description of the terms of the Underwriter&#8217;s Warrants is qualified in its entirety by reference to such exhibit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in; text-align: left"><b>Item 8.01</b></td><td style="text-align: justify"><b>Other
Events.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September&#160;25, 2023, the Company issued a press release announcing
the pricing of the offering. A copy of this press release is attached as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K and
is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September&#160;28, 2023, the Company issued a press release announcing
the closing of the offering. A copy of this press release is attached as Exhibit&#160;99.2 to this Current Report on Form&#160;8-K and
is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in; text-align: left"><b>Item 9.01.</b></td><td style="text-align: justify"><b>Financial
Statements and Exhibits.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1829635/000110465923103270/tm2324931d8_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></a></td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1829635/000110465923103270/tm2324931d8_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Underwriting
    Agreement (Incorporated by reference to Exhibit&#160;1.1 to the Registrant&#8217;s Amendment No.&#160;2 to Registration Statement
    on Form&#160;S-1, filed on September&#160;25, 2023 (File No.&#160;333-274251)).</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1829635/000110465923099406/tm2324931d4_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1829635/000110465923099406/tm2324931d4_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Pre-Funded
    Warrant (Incorporated by reference to Exhibit&#160;4.2 to the Registrant&#8217;s Amendment No.&#160;2 to Registration Statement on
    Form&#160;S-1, filed on September&#160;25, 2023 (File No.&#160;333-274251)).</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1829635/000110465923099406/tm2324931d4_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></a></td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1829635/000110465923099406/tm2324931d4_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Underwriter&#8217;s
    Warrant (Incorporated by reference to Exhibit&#160;4.3 to the Registrant&#8217;s Amendment No.&#160;2 to Registration Statement on
    Form&#160;S-1, filed on September&#160;25, 2023 (File No.&#160;333-274251)).</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2327131d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: top"><a href="tm2327131d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, dated September&#160;25,
    2023.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2327131d1_ex99-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></a></td>
    <td style="vertical-align: top"><a href="tm2327131d1_ex99-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, dated September&#160;28,
    2023.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive
    Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TransCode Therapeutics,&#160;Inc.</b></span></td></tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; width: 50%">&#160;</td>
    <td style="font-size: 10pt; width: 5%">&#160;</td>
    <td style="font-size: 10pt; width: 45%">&#160;</td></tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: September&#160;28, 2023</span></td>
    <td style="font-size: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="font-size: 10pt; vertical-align: top">
    <p style="border-bottom: black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Thomas A. Fitzgerald</p></td></tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; vertical-align: top">&#160;</td>
    <td style="font-size: 10pt; vertical-align: top">&#160;</td>
    <td style="font-size: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas A. Fitzgerald</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVsKwkAMRVfQPYT5LtoHivZPi4pYRUoRfwebymA7KZnxtSR36bRFDIGQ3HtyhfDFhtaqRobzMs+gwKatpUXIsUJGfUHnSLe7BNzM8aqMZaltv/7AlByDjpmM5tLde+dDGSwTCGbjKB5HIQTzJJ7CYi+8Tk9JV6pEbZWsQeoSjkwtK7SS38OHQr5IU/Puk07IRpFOIBwFg/yBKAgjONBDPolvBrIsFZ7flyc2TPe2i7kbSw2samxclhnQf3tf3eBJGA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2327131d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm2327131d1ex_99-1img013.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TransCode
Therapeutics Announces Pricing of $8 Million Public Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&nbsp;26,
2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOSTON,
Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics,&nbsp;Inc. (Nasdaq: RNAZ), (the &ldquo;Company&rdquo;), an RNA oncology company
committed to more effectively treating cancer using RNA therapeutics, today announced the pricing of its underwritten public offering
of an aggregate of 15,700,000 shares of its common stock (or pre-funded warrants (&ldquo;Pre-Funded Warrants&rdquo;) in lieu thereof).
Each share of common stock (or Pre-Funded Warrant) is being sold at a public offering price of $0.51 per share (inclusive of the Pre-Funded
Warrant exercise price of $0.01). All of the shares and Pre-Funded Warrants in the offering are being sold by the Company. Total gross
proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately
$8 million. In addition, the Company has granted the underwriters a 45-day option to purchase up to 2,339,200 additional shares of its
common stock and/or Pre-Funded Warrants at the public offering price less the underwriting discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
is acting as sole book-running manager for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the offering is expected to occur on or about September&nbsp;28, 2023, subject to the satisfaction of customary closing conditions.
The Company intends to use the net proceeds from this offering, together with its existing funds, for one or more clinical trials with
TTX-MC138, its lead therapeutic candidate, including related investigational new drug enabling studies, and for working capital and other
general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities described above are being offered pursuant to a registration statement on Form&nbsp;S-1 (File No.&nbsp;333-274251), which
was declared effective by the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on September&nbsp;25, 2023. The offering is
being made only by means of a prospectus forming part of the effective registration statement relating to the offering. A preliminary
prospectus relating to the offering has been filed with the SEC. Electronic copies of the final prospectus, when available, may be obtained
on the SEC&rsquo;s website at http://www.sec.gov and may also be obtained by contacting ThinkEquity at 17 State St., 41st Floor, New
York, NY 10004.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor
shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful
prior to the registration or qualification under the securities laws of any such state or other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
TransCode Therapeutics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TransCode
is an RNA oncology company created on the belief that cancer can be more effectively treated using RNA therapeutics. The Company has
created a platform of drug candidates designed to target a variety of tumor types with the objective of significantly improving patient
outcomes. The Company&rsquo;s lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which is believed to cause
approximately 90% of all cancer deaths totaling over nine million per year worldwide. The Company believes that TTX-MC138 has the potential
to dramatically improve clinical outcomes in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas
and others. Another of the Company&rsquo;s drug candidates, TTX-siPDL1, focuses on treating tumors by targeting PD-L1. TransCode also
has three cancer-agnostic programs: TTX-RIGA, an RNA&ndash;based agonist of the retinoic acid-inducible gene I designed to drive an immune
response in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9&ndash;based therapy platform for the repair or elimination of cancer-causing
genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines designed to activate cytotoxic
immune responses against tumor cells.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains &ldquo;forward-looking statements&rdquo; that are subject to substantial risks and uncertainties, including
statements related to the completion of the offering. All statements, other than statements of historical fact, contained in this
press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the
use of words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;contemplate,&rdquo; &ldquo;could,&rdquo;
 &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;seek,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo;
 &ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;target,&rdquo; &ldquo;aim,&rdquo;
 &ldquo;should,&rdquo; &quot;will&rdquo; &ldquo;would,&rdquo; or the negative of these words or other similar expressions, although
not all forward-looking statements contain these words. Forward-looking statements are based on the Company&rsquo;s current
expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain
forward-looking statements are based on assumptions as to future events that may not prove to be accurate, including the number of
shares that may be issued and amount of proceeds that may be received by the Company pursuant to the offering, the satisfaction of
customary closing conditions related to the offering, timing and completion of the offering and various other factors. These and
other risks and uncertainties are described more fully in the sections titled &ldquo;Risk Factors&rdquo; and &ldquo;Cautionary Note
Regarding Forward-Looking Statements&rdquo; in the final prospectus related to the offering described herein, and the
Company&rsquo;s Annual Report on Form&nbsp;10-K and other reports filed with the Securities and Exchange Commission. Forward-looking
statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information
except as required under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
more information, please contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alan
Freidman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VP
Investor Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alan.freidman@transcodetherapeutics.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>tm2327131d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-family: Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font-family: Times New Roman, Times, Serif; text-align: right; margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2327131d1ex_99-1img014.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><B>TransCode Therapeutics Announces Closing of $8.5 Million Public Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">BOSTON, September&nbsp;28,
2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics,&nbsp;Inc. (Nasdaq: RNAZ) (the &ldquo;Company&rdquo;), an RNA oncology company committed
to more effectively treating cancer using RNA therapeutics,</FONT> today announced the closing of its previously announced public offering
of an aggregate of 16,863,000 shares of its common stock (or pre-funded warrants (&ldquo;Pre-Funded Warrants&rdquo;) in lieu thereof),
including the partial exercise of the underwriter&rsquo;s over-allotment option. Each share of common stock (or Pre-Funded
Warrant) was sold at a public offering price of $0.51 per share (inclusive of the Pre-Funded Warrant exercise price of $0.01 per share).
All of the shares and Pre-Funded Warrants in the offering were sold by the Company. Total gross proceeds from the offering, before deducting
underwriting discounts and commissions and other offering expenses, are expected to be approximately $8.5 million. The Company has granted
the underwriters a 45-day option to purchase up to 2,339,200 additional shares of its common stock and/or Pre-Funded Warrants at the public
offering price less the underwriting discount, which the underwriter has partially exercised to purchase 1,163,000 Pre-Funded Warrants
at the closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ThinkEquity acted as the sole book-running manager
for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company intends to use the net proceeds from
this offering, together with its existing funds, for one or more clinical trials with TTX-MC138, its lead therapeutic candidate, including
related investigational new drug enabling studies, and for working capital and other general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities described above were offered pursuant
to a registration statement on Form&nbsp;S-1 (File No.&nbsp;333-274251) declared effective by the Securities and Exchange Commission (the
 &ldquo;SEC&rdquo;) on September&nbsp;25, 2023. The offering was made only by means of a prospectus forming part of the effective registration
statement relating to the offering. Electronic copies of the final prospectus may be obtained on the SEC&rsquo;s website at http://www.sec.gov
and may also be obtained by contacting ThinkEquity at 17 State St., 41st Floor, New York, NY 10004.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in
any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification
under the securities laws of any such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About TransCode Therapeutics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TransCode is an RNA oncology company created on
the belief that cancer can be more effectively treated using RNA therapeutics. The Company has created a platform of drug candidates designed
to target a variety of tumor types with the objective of significantly improving patient outcomes. The Company&rsquo;s lead therapeutic
candidate, TTX-MC138, is focused on treating metastatic cancer, which is believed to cause approximately 90% of all cancer deaths totaling
over nine million per year worldwide. The Company believes that TTX-MC138 has the potential to dramatically improve clinical outcomes
in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. Another of the Company&rsquo;s
drug candidates, TTX-siPDL1, focuses on treating tumors by targeting PD-L1. TransCode also has three cancer-agnostic programs: TTX-RIGA,
an RNA&ndash;based agonist of the retinoic acid-inducible gene I designed to drive an immune response in the tumor microenvironment; TTX-CRISPR,
a CRISPR/Cas9&ndash;based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an
mRNA-based platform for the development of cancer vaccines designed to activate cytotoxic immune responses against tumor cells.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains &ldquo;forward-looking
statements&rdquo; that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained
in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by
the use of words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;contemplate,&rdquo; &ldquo;could,&rdquo; &ldquo;estimate,&rdquo;
 &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;seek,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo;
 &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;target,&rdquo; &ldquo;aim,&rdquo; &ldquo;should,&rdquo; &quot;will&rdquo; &ldquo;would,&rdquo;
or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking
statements are based on the Company&rsquo;s current expectations and are subject to inherent uncertainties, risks and assumptions that
are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove
to be accurate, including expectations regarding the use of proceeds from the offering. These and other risks and uncertainties are described
more fully in the sections titled &ldquo;Risk Factors&rdquo; and &ldquo;Cautionary Note Regarding Forward-Looking Statements&rdquo; in
the final prospectus related to the offering described herein, and the Company&rsquo;s Annual Report on Form&nbsp;10-K and other reports
filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date,
and the Company undertakes no duty to update such information except as required under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>For more information, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: #FEFEFE">Alan Freidman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: #FEFEFE">VP Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: #FEFEFE">Alan.freidman@transcodetherapeutics.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>rnaz-20230925.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa+MubOdzZR+yYkxtmB9bYm6nyUoK5klGyLeGC8mEVwO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:rnaz="http://transcodetherapeutics.com/20230925" elementFormDefault="qualified" targetNamespace="http://transcodetherapeutics.com/20230925">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://transcodetherapeutics.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="rnaz-20230925_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rnaz-20230925_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>rnaz-20230925_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>rnaz-20230925_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://transcodetherapeutics.com/role/Cover" xlink:href="rnaz-20230925.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://transcodetherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2327131d1ex_99-1img013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2327131d1ex_99-1img013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ^ :(# 2(  A$! Q$!_\0
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M4K.W^6-,^<&!P"#_ &WR(FT?*OWX_P"$?\]%]J_CL_X(5@'_ (+&_P#!4<$
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MEYIFJ^8\T,>F-$8IOZ-OC%_R2?XF?]D_\:_^HOJU?P:_\$@/^"6_P!_X*6_
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H]KMO3S=_N\CO"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2327131d1ex_99-1img014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2327131d1ex_99-1img014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  _ :(# 2(  A$! Q$!_\0
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M4K.W^6-,^<&!P"#_ &WR(FT?*OWX_P"$?\]%]J_CL_X(5@'_ (+&_P#!4<$
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MEYIFJ^8\T,>F-$8IOZ-OC%_R2?XF?]D_\:_^HOJU?P:_\$@/^"6_P!_X*6_
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,4 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139769331416880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 25, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 25,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TRANSCODE THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001829635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-1065054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6 Liberty Square<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">#2382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">837-3099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RNAZ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>tm2327131d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rnaz-20230925.xsd" xlink:type="simple"/>
    <context id="AsOf2023-09-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001829635</identifier>
        </entity>
        <period>
            <startDate>2023-09-25</startDate>
            <endDate>2023-09-25</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-09-25">0001829635</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="AsOf2023-09-25">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2023-09-25">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-09-25">2023-09-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-09-25">TRANSCODE THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-09-25">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-09-25">001-40363</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-09-25">81-1065054</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-09-25">6 Liberty Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2023-09-25">#2382</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-09-25">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-09-25">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-09-25">02109</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-09-25">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-09-25">837-3099</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-09-25">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-09-25">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-09-25">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-09-25">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2023-09-25">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2023-09-25">RNAZ</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2023-09-25">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-09-25">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2023-09-25">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M;%!+ 0(4 Q0    ( /2 /%=>D"&T[P   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( /2 /%>97)PC$ 8  )PG
M   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ ]( \5_K4[.J/!   RA$  !@              ("!#@@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( /2 /%>?H!OPL0(  .(,
M   -              "  =,,  !X;"]S='EL97,N>&UL4$L! A0#%     @
M]( \5Y>*NQS     $P(   L              ( !KP\  %]R96QS+RYR96QS
M4$L! A0#%     @ ]( \5ZK$(A8S 0  (@(   \              ( !F!
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( /2 /%<D'INBK0   /@!   :
M              "  ?@1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( /2 /%=ED'F2&0$  ,\#   3              "  =T2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  "<4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2327131d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://transcodetherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>rnaz-20230925.xsd</File>
    <File>rnaz-20230925_lab.xml</File>
    <File>rnaz-20230925_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2327131d1_8k.htm">tm2327131d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2327131d1_8k.htm": {
   "nsprefix": "rnaz",
   "nsuri": "http://transcodetherapeutics.com/20230925",
   "dts": {
    "schema": {
     "local": [
      "rnaz-20230925.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rnaz-20230925_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rnaz-20230925_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2327131d1_8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://transcodetherapeutics.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2327131d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2327131d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001104659-23-104743-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-104743-xbrl.zip
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M0J=Z*:I7@%;J&;&R"O2[J@3EM=A^O[R^Z5I^DIOU)OG7"J=$;ODO4$L#!!0
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MWS&#\D7,0BMDH>"](N))97,3K^Z5C"EUTR=Z<[8!$B)@!="0(.:G+T*!\[A
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M1,GL__>/8E79W2LX^TN;1"]C/J#MF2QW10?25<7-\-C0Q1#MM_)G)O&B9[L
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M;A]==$G[Z.JRW7TE^WSEN=RCEB#"AHX:5GE(L41LEQ0K6_J;5X+"[A,Q9 B
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M7DY.?XPB]6-2\EGB'@RNY%7#2@D]'K=9>7E&^1&P1LQY9B$P5 .?]]$U!,@
M5D0\*\BI>;KC:YU<NZ7+QH2:VT]>P.W9MLFH)7<=QUUB*A@^B[=WEWK%Y(]X
M9>2!,"Z8#L".ST><V(8$- B^A)752B#<<_L$<'O 5K'FMVH>MPE0*@^M<5TK
MK;@8521^"__W%?Z#0/@[X"HTX*4U. >S";;33)?\[5'S@^=L6[U_*FN7_$48
M7D[L9W.!./F3+9'Y8IGFBFI,[!-[8I)"7U;R?O,WO\7^AQ;[L!APY3(TM'C8
M0FY Q!# O>SWEV4\5^7/0W&E?_0ZM;6+_W)87DX-8,Z<%IOT<6Z@6-9SZE;O
MC?_I\9KA]_JM&S^V;BCINM'BW&/N@QIR=J0Z)V+PL=$HOK2&+$#TP^E)B>7*
M6]JJ>A+T>GT]>?Z L9#0SX>8RW1,XX$N/19_YJ3M>$7S$.9,0)O\KYHBA2N=
M"U;AH2,\X4:&[3^7%EBZ>%S9W^.J#8EF4L[]JDG:<FJTT>+^2E1:UT>"JBKW
M@.I263/FTU'/-K?XF^\)Z'TTO0AV^TF2LE"[0:+'0P.>A"M-,_&/$(GOMUC-
M0:2"\D0WL7QY,E#H:5'M2<%)-_KFQWIE\'?U8^/.>&(A>'Z>S#Y:>J!@1]C:
M;98XU"5WU/08^8^2QY.HQ,$CJ\-G[.%:54Y>EN#A-O) YCM2Y-.IW3OY6AJZ
M5:M>6BT(G5$[,4EFOWW1^/QS4K$[9,O*.:%$A<YV^2;E>N/N\YUV[=Y]&V;V
M5SE*/K_JB9J_N."9!D@&3 ;7Z==YJH?EDB9U# $IZ3EU;YE8ODEK73L[7JU*
MV[)T#)H8Z4V))BNVT.46[*2\B6*^D&IP KR%B M''9"!:X_%<',#@B\'JZN4
M$YWU#<O?3XUQ%RDK%;)XC&5V>J5$MA#+6G 809:IPBXP&W#(D=NQ(62)Q7%J
M+Z<N#KNYD7H\)CD!!G2S[K$I7C"X>>8B,7)J^1*Q:PR&(G5'#P;*1TE>D8!5
MB0,@3TE*DMMEPEE.Y"1-?XXE&7NK\:G^SKER+WO/S4>$Z['%=?U46"1+5.7!
M3.0'DH"'5;>?HHPA@W$U-%6SC?G5D<V-(>@M,R'F![VU;)D!>)S)9C"I7(4A
M\H(:0V8%_IT-R! YF3G%V<<&S(TVP )\X(W+[@P._< :4$O#:A[5Y-5 ,GX4
MU-*IJW-_^46/I1]RN2?(/\*D;8M&24A<P?-/%.(G5F0#Z9IT(TKXA[G2Q5SY
MY_VGJBD4^^^G'RE;EG8O@V3%=#M=-&O/%/79GV<+?;Y6D1M;7N@FAEA*D9IR
MQ&YJ6/>*[:I$#BBQ9J-R#WT1^%WH]-7#"@N,[6,B8\=%HBY-U>(^JZBF[&NJ
M2@ 6+Z%(8AO>Y[$PO<OH;:['0&D 1D?"')^RFC(C@K'JE''>KG4A/FG6I2=_
M8=<1S)%2=XG76>;K,$^$8.E>X_F=$_?FVDD$OGA<&/VIO.LJI3I;JQA6FK/$
MW=F"C4@QKQ1GR7YZ&A1- 9V.\(S2YH9A@5NB)%P'(X<8YAIR3UUCX#)9@\S'
MJB$R(_BQLX',_B5D\^$!Y" Z#DXA9Y/;.7N@UA!>>):.Q3/;W<$Z"IY?7K;)
MVQ\-=WIG@6KAX2X2.[!!MM"=XV8NB,J:85 *GXJ[;[(AIM)1R9Q49A3( LM?
M^!N[_EHA#8F?&.\ZUF1S(V)0.+X?K'2'AG5[]-4#5TK.SII9S%ZBL2'U21T0
M"14 F:B8^G4E[-$,<R&<5<=W!I;%-S<@Y"$<] HC,R"*X_5,B 5LK),C)O'I
M+H.'L[D ;SJ $0?!>?@M(RABUQ0EJR@*"6Z6VPI&\"^7BA .HJ<8G7$+G4S<
ML*;#'ZSIS+,KJ@3%0=0!K! NQV6YOB=#1V ]QIDSX+!X?^R_^QB\"X>1X1\0
M%J(\B$"+U6RQ6HKC!X@DZU"SC:S%J&W*^ EF(2J JS#\O;&N!I%J2*(Y3OMD
MLL$J@7$P;2%%S7:D!,<A]1S\J&9+I7I6!1#0EF(CF"$=<B17 >+D%%CS()J0
MUOK=QB#[Z$UU0B$V7A0;!P(\"3RPK.(S3/;T^8$8I5$C/FJ*+"8&5>2@BZ-D
M-S=\J7<9,)LS'%=2-I*9]&$Q;\!V<=D#(\W]WBAY<;F+^#/K+(NZW(-_9D!M
M;@10^<03-A9KP&1QF6)HH(F<]%U[).<(U2M+_-"!P ">)NU)PKCH!I<I"Y>T
MU**36?YG__!;A!R;.,SB6(1PZ%0ZU=XTKG3 $#?8"C<Q<(N#.27_V<Y7""0@
M)@SJ QY9#Y,'AD-/$\D9)P-QCK7)AC1#()+ZM%TN98N5Y<J$PF#-D]P7@VJI
M5IFQQ0<VPETS;<SU[$5_LNW[DQ^KMC(W8%>FPX$,^^N'V=!H8;'*9_X=LR3!
M,7FC88DK0?JDL_%U;$1UJ6C([5#P>\R"Z$&$%D=:(K;(223L++8@+2LR*EE?
M^N^!V?<V,Z C=X$R&.ZL1(='H9/<%8G6#1=/85+7X+< I!@S9CT>0DDFK![@
MM0IXB@0?^B<1^E03\_YA!-.",N!FSJ@8 $W#O3_HE*6;1/#$D,K2HV[TY46<
MPE?E,3[&<7J,W!EL[&,4[1[J37W;,@0SQUP)279V:-6P[AB\=G&C:3:NIWER
M#B8!+3XZE^B.9^2[QEP+<<;6W.M]81K.+X0T T%5)<$2B7-,D@!8><,$%C!H
M7P3U53WPZ<MIFPWB"YB4RY1,)$!#&@!B^ ,9 .3H>R90UF7]H*H#I R,,=HT
MT%8/P/SAE3*R+V/)5YTEO#B-:EB2")',H1F:;2KNY(J;&]'Q =FR$[6\L(,:
M4JE4RJFULEHIOL$-Q1BT8(@X5[5&;D8%J-E!W878R'\\"[XLTO &D%,$-K$.
MGM,/LG' QP7:=.2K[**)+1;#D!U'6QK/^Y*(]7G-I!A.,R"NA@G,YL;,4848
MI5CRZ'XB&93G20,TPHEMJ'9']\LP*K!/6HK76 V-GA$0I)@O C_!4V$UWK_8
M*0I>=,8UUW#B^[I!;4;\X;F^>F!%8E>[$#R:ZS*P*SVI&?Z-OBA(TI@R'Z*\
M3&0B=!:CGN5HE"4:Y"E8I(1HD'(^&0<21^&>Z.$^7-00E_"NK=59DA:N/!VI
MU]AZ\FN40+97+(%<HL/<W#C"F]?XOZK($<_7@V ;DB$\UP2":#(,F:EE@3G6
M9&PG8R&(B>5Y$U_80Q>5M(<&GQL%UTV%@+PE1=?J]9CA:'JN#'""^^\2K@S/
MQX 22LLPN_P"1@3V,-"EN/K\T+X]A27;SV )QC-K9XGZ:['D,6L ZN\U@)=8
M _CE_5$=_%%^%8=T'*XI;VY$L7P8G4LM_OF\U)8>Y,4A!O_VG;:/O"EHCY)A
M])U'?.Y;,!JN-H0$AA>8/J!N ?)H6@B^$:. Y>NB4JY6ZFJIJ)34FE(0([6D
MENNEHKY]PR;%7#$_%*-UWGH#B4RTN$X?>8?2SX?ES/O%LPOIC1'761*VU8I[
MQ/G@/B4%E.X[Y:1_]+TPLX1=NN?TK-X'8[X(D TRG>69+=GR;\)*J0G@WK D
M7Y]P+=M:F*S4ZV6E&F-R&9A<SJGK9G+YNXKR:V&9$.7X8@)B&B;)*XAQE#:O
M08Q!4GTX?ADQ?@%;!0SYT<3XU2QR? 'SR?)<^G7D6;*I5@0V%8%-]7K I[ S
M;BC/04#J4@TBHJ JM4XN8AW@F<+ZO5&XBF?86;FPD5:2]K$*U@5?D('JJS/P
MN=;F>Z/P* 9NKYN!ZPO E?)*UQ>O>?HFKAK*LDFX_PF,, T661"40_ 41)JS
M+22HK@<+3<%*<DM^P2S!;Y@E>O"%$3$;]T*G3N_?'_@SWYCUB)I6Z7=-Z^7W
MM;[V/6F=ULE%HWO=/OJQ;Q\+X#<LO#48"V45O%G@:FZCFHO?7>P&-:Y''GG*
MSI_;PA,>NF=.B48]W*D37Z3T3X)S(*(?A^&27(\-J=D/=S#)35%! RQL>[@3
M4PY'/3&T73"!^B]S-'S.ZN^21Y\57_ 7J<<R86*T]V\S:F;IE '>.:RCAL\2
MLI0+K@1]D0N=R9*MOO==7;^4!@]1*>)317G@RP66=GQBO_)<QS6A\\(Q"'ZO
MU,ZRY;5[@Z/7AO1@NK,&>.:O=)_SW#WIN?V3+O'#/$^R2P5> -F'AI#[YL%Q
MBF\#4 13G[_?_45$9"41?J$1UL?\=#*N9#O6;GG7T/A[F.;FT&!]$JV)X>YF
M0\/O//CI+JMY3,!>WB67<N\1W_$OFOUAXO?76R!>'Z5Q=;1GZU.Y3#H4(W,_
M2?T. ]+@_0@[9*)/=DGK4/YRHVP?W,BCP?YV>(FI[,?>3XZ__,U/Q[>-\_;?
M_0]7_W0K9\)^9]Q]OC+*SC_M:[O='[/>=-2HG7ZV)J+3+E5[[>/#ULF'TCLQ
M'?8/CX>"?FW;O6_G_*_!^)0*Y_I3BU^_/^E?O[,Z9ZQV</'M?)M^/?],37%7
MJ#7,@^GA%V=T7A%G.OM+/SSIC+O-D]Z7TX/*N]:'[K?W[VO-?XR_MKNW]?=_
M5YVCWN>/_ .S.U]NQ^*TUNF4MB_??7 KK>O"E7>KU%IMY_BR=3 ^'A2F!Z>-
MP9?+BX/#*]N\.W!;_/ASK6].-;5[Q52C=MOKC%5.1Q/-'%H?^B71+[&#]R>-
MMV]]DOP_4$L#!!0    ( /2 /%>?<K%P^0L  .XO   6    =&TR,S(W,3,Q
M9#%?97@Y.2TQ+FAT;>U:;6_;.!+^;L#_@1OL%2E@.W;2;C<O6UR:.MW@TB2(
MC>WUOAQHB;;92*1*4G9RO_Z>(259EI,N[M(".5SZ(;5%<F8XK\^,?/3[^./Y
MVW;KZ/?A\7O\S^C?T?AL?#Y\>[03_L?J3K%\].[R_6<V&G\^'_ZV-=7*';!!
M/W-L+%-AV858LFN=<M4)#SIL)(R<;N$@CE[]I^<.6<K-3*H#UM]Z>W1Z>3&N
M4^A.>2J3NX,_H^'W6ODO$5ANO7VA)C8[/-HA@KCCU7\MG1.WKLL3.8.$1L[F
M[@<)?/3N[?!V+B?2M5O[^[W!T<Z[M]]!_*>MW!^CR;./']CH^N2W+9?N[NV^
M&>P-XH&X_>?^?G<@TUE_L-?[DLVVV/'Y^+>M'W$9;'WBZO[>$L)YQX8K>Z)C
MT6Z-Y\+P3.1.1I8=*Z5S%8'<E9&15#.FI^SG7]E'F212*W:53Q(9L<OI%+35
M['N[_?^?+48B<R*="!-$W?VETV[M]G?WGK+,3U^K[RY'X\L+J)+4VV.[KSN,
ME,JV/YQ?OANRB^&GT:>SZ^%+UNVR*A18/1(ZX9)G*NJQ[0MN8_[U@%U?'/_C
M98=MN[E@+Y+X:ZX/3W2:<77WPOAO6.2*MC&M(IWHV1V+PH9V"Q]2Z9R(F=,L
MU48P@2B*G%R(Y(XY([BC>(LXPL^PW-(7HN3J4N%LS._ )(1I3*LL6X6J=);E
M*A9F:8B78ED(6%T$;+N%31"1SV9&S+@3=&CPNO.FW^_T^WUFY]Q TP4E$AE!
M;YV.;MBV-N DNE.B'[,E-U <-FT7FKC"VFE8^U2LE5IA4K%$BMS?1>CIRUZ[
M->31/+ C;AN<-JF!BF4301>U.HD9=XPWK^=5X0G^W.^]'K ,F@P\MJ6*$BAU
MX5=):RL.[5;!@HE;82)IQ1J=_N!ECQTG27FPT!%7\3U26KHK[:I$(NXUL2=W
M?KGPFQX;:\<3-C/:VG8K,SH2(K9L:G2Z1J8#&E-R&O#*(^\IE9WI2RQM!)=P
M02[O:]8B8X?OFA2_$DG<9D)9"B 2CKY%A5].!.,9I+B5*9PC@=LB^:<A^??8
M&1PGCL%0(P1KMV!S;G$%7+_PR$HT82  >_6Z2UZK,SI);++<1#B#C1E]W>WL
M[>UW=N%_)7FH9,T50_A4'H([[=SK));<PL?$O8Z1"&O7!:SKKO>44]K33[KC
MN50WPZ^Y=' ;Q"H/;@K7@.,C!K2^Z9I<*7H(>GP&EX1+K[GYLPD>:0( NBC1
MMB@':XD()JF'NHZB'#E!,9B 3W3N6!.+_!JJ9H?9?/(%Y^B43X"H5'9*YJ73
M2-XYHA)W0K$K6$=:A3BV/0\PJT0AD2(4\ALHY0A_HJ:$8\V\)VTM\3D]$SY_
M+:6;^[HD;J7UOD6U".H@+])*T$U\88T2J62$'.*,Y(GU!R''^._=CR>#/5R+
MB"2"Q_7B2I4WEC'2'M:I6,3$P8B$D\*D6@CP1,D,V4G!)K')D4L51Z:A[.YP
MPN=4)%R2:*G-3:CHF:0<7R7B=FLF%/@FT)/)M*$RC(R8::3DYP!X? !8 <^&
M^^%D+&QDY 0&A(NC]J^*L?<O/(?B;4ZU'R[)8>X97,MX*\.BL$PJL(8OI]JD
MX?ZC[H!MGTJDM O="X_V]O:ZNV]>[;X>  $NYS*"NRTYL8\23EPJJ%?6_]%*
M1O*+X2WJH9KY0"DJ]QK,' U/*C"%I6:D%OBV1Q"V'O#M5KALR@%OM0+.!/M4
M /!2W'**.TL9(;?DL:DOE-RX,G6LI'Y +SXZZ%21&:HTSHX)*R82))$7/+ I
M&3UTQH.(B0!FG4*W<8AVKZKA28\-$YPV6E&<ZDP&8$"K4TGAN*)/^@<-ON R
M060BF%- #^ :/7%<*D)[6I5T7QA+.D6&$!,+M$+H8>Y<=K"SLUPN>W"DWDPO
MO(6("G*)KI,B;2+5N:+2U0H@$1J\82/2%/[V.NS5P#IVFFAM.N3/[=9GI =\
M_ S/[?=?/<?]8[&'A\^$[^!@@K E "1 N]*.;(3<[7(RL H.1]YG!8%Z5#\"
M*&BA'"\K6GW7)*=^ZZY"__<E%VIK)*14&LD]\/6MCL?3.&MY4O8==HT$F@6_
M[OV$JI@O=%^P;&,9"BRV^(R"*HP_7JQ.0V 3&"QU3@T&H=N$+Z=Y0AJ1VI21
MMA;$>/PUYXF<HE#Z!QX2-Z\(.B%5D)#$_QN2/KOP8Z=RQP3# %3NG4@\S]H>
MG2160T]J3^X?U+"()C&(Z:)*3%#%!$4N,GHQF\%_%&7WSW!P\O[932C.M8X9
M2+TX@$*,FD@5F&+-P\H*C/HT(V<J@'8'W0@:?"RXD<*%K)2G%.-WF;"KHJD]
M8B_&'73>![IR$%.FJ):+4.L1Y H>![?#]<6ZC%5Q_!92KH-J A'H!0K=E0.M
M5#A.62.<BRA[A7SFQSE0[B)<+>(XVFZMC1_8?O\O/OT@H1;*CT%V3@T$(+7'
M<0L\1$\IRC&%'_K<">X!>!(O92S655\PM<&FU04\_O"C XT>Q:%Q:+<@5FQX
M2L)#A%)UM0:C5)Q/Y,QX"$<=D9?5UAN)"?1A70<Z5][L,NI =EB1IG%^9)-
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M^9[#T2)DN_1'9.&ORNB/S_X#4$L! A0#%     @ ]( \5VNZJ4HR P  "@P
M !$              ( !     ')N87HM,C R,S Y,C4N>'-D4$L! A0#%
M  @ ]( \5\G4=:?]"@  @(8  !4              ( !80,  ')N87HM,C R
M,S Y,C5?;&%B+GAM;%!+ 0(4 Q0    ( /2 /%?([-+ 80<  .]7   5
M          "  9$.  !R;F%Z+3(P,C,P.3(U7W!R92YX;6Q02P$"% ,4
M" #T@#Q7$BGI\F47   RB   $@              @ $E%@  =&TR,S(W,3,Q
M9#%?.&LN:'1M4$L! A0#%     @ ]( \5Y]RL7#Y"P  [B\  !8
M     ( !NBT  '1M,C,R-S$S,60Q7V5X.3DM,2YH=&U02P$"% ,4    " #T
M@#Q76!/J/\ +  "#)@  %@              @ 'G.0  =&TR,S(W,3,Q9#%?
@97@Y.2TR+FAT;5!+!08     !@ & (T!  #;10     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
